论文部分内容阅读
选取2013年3月~2014年1月在我院进行治疗的40例胆汁反流性胃炎的患者,随机分为对照组和治疗组,对照组采用莫沙必利治疗,治疗组在对照组的基础上采用铝碳酸镁治疗,比较两组患者的临床效果。结果治疗组的总有效率为90.00%,明显高于对照组的70.00%,两组患者相比具有显著性差异(P<0.05);两组患者治疗后临床症状评分明显降低,但是治疗组的降低幅度明显高于对照组,两组患者相比,具有显著性差异(P<0.05)。铝碳酸镁联合莫沙必利治疗反流性胃炎疗效优于单一用药,临床效果显著,值得在临床上推广使用。
Forty patients with bile reflux gastritis who were treated in our hospital from March 2013 to January 2014 were randomly divided into the control group and the treatment group. The control group was treated with mosapride, the treatment group in the control group Based on the use of magnesium aluminum carbonate treatment, the clinical efficacy of two groups of patients were compared. Results The total effective rate in the treatment group was 90.00%, which was significantly higher than that in the control group (70.00%). There was significant difference between the two groups (P <0.05). The clinical symptom scores of the two groups were significantly decreased after treatment, however, The decrease was significantly higher than that of the control group, with significant difference between the two groups (P <0.05). The combination of aluminum magnesium carbonate and mosapride in the treatment of reflux gastritis is superior to the single drug in the treatment of colorectal cancer. The clinical effect is remarkable and it is worth to be popularized in clinic.